Comparative Pharmacology
Head-to-head clinical analysis: PRISMASOL BGK 2 0 IN PLASTIC CONTAINER versus PRISMASOL BK 0 0 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PRISMASOL BGK 2 0 IN PLASTIC CONTAINER versus PRISMASOL BK 0 0 IN PLASTIC CONTAINER.
PRISMASOL BGK 2/0 IN PLASTIC CONTAINER vs PRISMASOL BK 0/0 IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Prismasol BGK 2/0 is a bicarbonate-buffered solution used for continuous renal replacement therapy (CRRT). It provides electrolytes and buffer to correct electrolyte imbalances and acidosis. The mechanism involves replacing lost solutes and maintaining acid-base balance via the bicarbonate buffer system.
Prismasol BK 0/0 is a sterile, nonpyrogenic bicarbonate-buffered replacement solution for continuous renal replacement therapy (CRRT). It acts as an electrolyte and buffer replacement to correct acid-base disturbances and maintain fluid balance during hemofiltration, with no pharmacologic active drug component.
Continuous renal replacement therapy (CRRT): 2.0 mEq/L potassium, 2.5 mEq/L calcium, 1.0 mEq/L magnesium; flow rate 2000-3000 mL/h (1000-1500 mL/h if BGK 2/0 is used specifically for hemofiltration). Intravenous via hemodialysis/hemofiltration machine. Not for direct infusion.
Administered as a continuous infusion at rates typically between 1000-4000 mL/hour depending on the desired effluent flow rate, patient fluid balance, and metabolic requirements. The solution is used as dialysate (hemodiafiltration) or replacement fluid (hemofiltration). Must be prescribed and administered under physician supervision using intravenous infusion via a dialyzer or hemofilter.
None Documented
None Documented
Not applicable as a drug; PRISMASOL components are endogenous or rapidly equilibrated. The terminal half-life of infused components (e.g., bicarbonate, electrolytes) is minutes to hours depending on patient's metabolic rate and CRRT clearance, with no relevant clinical context for a terminal half-life.
Not applicable; PRISMASOL is a dialysate solution, not a drug with systemic absorption; components are removed by dialysis.
PRISMASOL BGK 2/0 is a sterile hemofiltration solution for continuous renal replacement therapy (CRRT). Its components (electrolytes, buffers) are not excreted via renal or biliary routes; they are administered as replacement or dialysate fluid and are eliminated primarily through the CRRT circuit and endogenous metabolic pathways. No significant renal or fecal excretion applies; the fluid and solutes are removed via ultrafiltration and diffusion during therapy.
Renal (80-100% in urine as unabsorbed, not metabolized); minimal biliary/fecal.
Category C
Category C
Dialysis Solution
Dialysis Solution